If you are having trouble viewing this email, view online version .

ESE Daily News Alert - 31 January 2020

Safety of menopause delaying therapy questioned

Fertility experts have expressed concerns over the new menopause delaying treatment being offered by some private clinics.

BBC News

IGF-I normalisation reduces acromegaly deaths

According to a study, published in the European Journal of Endocrinology, IGF-I levels are more important in determining mortality risk in acromegaly patients than growth hormone levels.


New GLP1R insights may lead to better diabetes therapies

Glucagon-like peptide-1 receptor (GLP1R) has been more extensively characterised using advanced imaging techniques, which may aid in the development of better diabetes therapies, according to a study published in Nature Communications

Medical News Today

Daily administration of progesterone could prevent miscarriage

Data, published in the American Journal of Obstetrics and Gynaecology, suggest that progesterone administration could prevent miscarriages in women at risk.


The European Society of Endocrinology is Europe’s premier learned society promoting research, education and clinical practice in endocrinology for the public benefit and representing doctors and scientists who work in endocrinology. For more information, visit http://www.ese-hormones.org/

This news alert is designed to provide European Society of Endocrinology (ESE) members with a summary of stories on endocrinology currently appearing in the media. The views expressed in the stories featured in this update are not necessarily those of the ESE. The ESE accepts no responsibility for the accuracy or completeness of the material contained in this alert.

If you know of some European media coverage that would be of interest to the ESE membership, please contact the ESE press office.

Please note that the address that sent this email is not monitored and we cannot respond to direct replies.

Stay connected